Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors
So far, the studies demonstrate that Lynparza has activity in cancer patients with and without inherited BRCA mutations.
Chatting With Anne Parker: A Patient’s View On How Cancer Care Has Changed Since The 1960s
Anne Parker’s perspective on cancer care – as a family member, patient and advocate – spans over 50 years.
Don’t Judge Her
What’s great about this piece, and what’s wrong about it, is that it comes from an individual woman.